Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 13.6d

Immunosuppression Use for Maintenance by Regimen

Prior to Discharge, 1999 to 2008

Recipients with Heart-Lung Transplants

  Transplant Year
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Functioning Graft at Discharge 34 33 21 22 17 35 29 24 29 21
With Immunosuppression Info 33 33 21 22 17 35 29 24 28 20
Tac 0.0% 0.0% 0.0% 0.0% 5.9% 0.0% 0.0% 0.0% 0.0% 0.0%
--- + Steroids 0.0% 0.0% 4.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
CyA + Steroids 12.1% 3.0% 0.0% 0.0% 0.0% 2.9% 0.0% 4.2% 0.0% 0.0%
Tac + Steroids 3.0% 3.0% 0.0% 4.5% 11.8% 11.4% 3.4% 4.2% 14.3% 5.0%
CyA + MMF/MPA + Steroids 30.3% 36.4% 33.3% 22.7% 17.6% 17.1% 10.3% 8.3% 3.6% 5.0%
Tac + MMF/MPA + Steroids 18.2% 9.1% 19.0% 18.2% 5.9% 34.3% 41.4% 62.5% 67.9% 85.0%
CyA + OtherAntimet + Steroids 18.2% 33.3% 38.1% 27.3% 23.5% 14.3% 34.5% 12.5% 0.0% 5.0%
Tac + OtherAntimet + Steroids 6.1% 6.1% 4.8% 18.2% 29.4% 14.3% 6.9% 4.2% 10.7% 0.0%
Tac + Siro/Evero + Steroids 0.0% 0.0% 0.0% 0.0% 0.0% 2.9% 0.0% 0.0% 0.0% 0.0%
Other Regimen 12.1% 9.1% 0.0% 9.1% 5.9% 2.9% 3.4% 4.2% 3.6% 0.0%


Source: OPTN/SRTR Data as of May 4, 2009.

Percentages in each column sum to 100 percent.

---: No Calcineurin Inhibitor Use; CyA: Cyclosporine; Tac: Tacrolimus.

MMF: Mycophenolate Mofetil; MPA: Mycophenolate Sodium; Siro: Sirolimus; Evero: Everolimus; OtherAntimet: Antimetabolites excluding MMF and MPA.

"Other Regimen" includes drug combinations that are different from the listed regimens and drugs from the text field entering.



PDF FormatRequires Adobe Acrobat Reader